Going Virtual

08/05/2020 By Andrea

Contributing Author: Chris Mycek, President at WORLEY Pivoting to virtual….Google it, you’ll find it’s a common current theme that will have enduring repercussions on how things get done. Zoom is a new household word, and now a verb as well. Amazon Prime, Netflix, FedEx, are all booming. Nesting at home, with new entertainment centers, pools, […]

Speaking the Language of Powders

03/13/2020 By Andrea

Author: Casey Muench Bickhardt, President, GEMCO In the pharmaceutical industry, the precise mixing and drying of powders can be critical to the safety, consistency, performance, and cost effectiveness of a wide range of tablets and capsules with trace levels of additives and active ingredients. A host of variables, such as powder size, shape, density, chemistry, […]

Whitepaper: Execute a 5-Step Framework for Data Compliance in Healthcare Marketing in the 2020s

The 2020s will transform how consumers and businesses interact with each other as vast amounts of personal and contextually relevant data will be … FREE Download

Automation of Process Control within the Pharmaceutical Industry

While most pharmaceutical businesses have adopted process automation in one format or another, the technology has evolved considerably over the past … FREE Download

Alnylam reports positive results from ILLUMINATE-B phase 3 study of Lumasiran

10/01/2020

ILLUMINATE-B is now the seventh Phase 3 study of an RNAi therapeutic that has yielded positive results, and the first-ever study evaluating the safety and efficacy of this The post Alnylam reports positive results from ILLUMINATE-B phase 3 study of Lumasiran appeared first on Pharmaceutical … [Read More...]

Pfizer to acquire minority stake in CStone Pharmaceuticals for $200m

10/01/2020

Under the deal, CStone and Pfizer will involve in the development and commercialisation of CStone’s sugemalimab, an investigational anti-PD-L1 monoclonal antibody, in mainland China. They will also co-develop The post Pfizer to acquire minority stake in CStone Pharmaceuticals for $200m … [Read More...]

Baylx receives US FDA clearance of Covid-19 IND application for umbilical cord tissue mesenchymal stem cells product

10/01/2020

Mesenchymal stem cells hold great promise to treat COVID-19 patients due to their potential in inhibiting the overactivated immune system and promoting the recovery of pulmonary and other The post Baylx receives US FDA clearance of Covid-19 IND application for umbilical cord tissue mesenchymal stem … [Read More...]

MedinCell begins first Covid-19 clinical study with Ivermectin

09/30/2020

The randomised, double-blind, exploratory phase I trial A has been designed to evaluate the pharmacokinetic profile, safety and tolerability of a continuous daily dosing regimen of Ivermectin in The post MedinCell begins first Covid-19 clinical study with Ivermectin appeared first on Pharmaceutical … [Read More...]

Featured Article

Going Virtual

Speaking the Language of Powders

White Papers

Whitepaper: Execute a 5-Step Framework for Data Compliance in Healthcare Marketing in the 2020s

Automation of Process Control within the Pharmaceutical Industry

Industry News

Alnylam reports positive results from ILLUMINATE-B phase 3 study of Lumasiran

Pfizer to acquire minority stake in CStone Pharmaceuticals for $200m

Baylx receives US FDA clearance of Covid-19 IND application for umbilical cord tissue mesenchymal stem cells product

MedinCell begins first Covid-19 clinical study with Ivermectin